検索結果 - Suvi Parviainen
- 検索結果 1 - 5 結果 / 5
-
1
Favorable Alteration of Tumor Microenvironment by Immunomodulatory Cytokines for Efficient T-Cell Therapy in Solid Tumors 著者: Siri Tähtinen, Saija Kaikkonen, Maiju Merisalo-Soikkeli, Susanna Grönberg-Vähä-Koskela, Anna Kanerva, Suvi Parviainen, Markus Vähä‐Koskela, Akseli Hemminki
出版事項 2015Artigo -
2
Oncolytic adenovirus and doxorubicin‐based chemotherapy results in synergistic antitumor activity against soft‐tissue sarcoma 著者: Mikko Siurala, Simona Bramante, Lotta Vassilev, Mari Hirvinen, Suvi Parviainen, Siri Tähtinen, Kilian Guse, Vincenzo Cerullo, Anna Kanerva, Anja Kipar, Markus Vähä‐Koskela, Akseli Hemminki
出版事項 2014Artigo -
3
Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma 著者: Mikko Siurala, Riikka Havunen, Dipongkor Saha, Dave Lumén, Anu J. Airaksinen, Siri Tähtinen, Víctor Cervera-Carrascón, Simona Bramante, Suvi Parviainen, Markus Vähä‐Koskela, Anna Kanerva, Akseli Hemminki
出版事項 2016Artigo -
4
Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus 著者: Iulia Diaconu, Vincenzo Cerullo, Mari Hirvinen, Sophie Escutenaire, Matteo Ugolini, Saila K. Pesonen, Simona Bramante, Suvi Parviainen, Anna Kanerva, Angelica Loskog, Aristides G. Eliopoulos, Sari Pesonen, Akseli Hemminki
出版事項 2012Artigo -
5
Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy 著者: Otto Hemminki, Suvi Parviainen, Juuso Juhila, Riku Turkki, Nina Linder, Johan Lundin, Matti Kankainen, Ari Ristimäki, Anniina Koski, Ilkka Liikanen, Minna Oksanen, Dirk M. Nettelbeck, Kalevi Kairemo, Kaarina Partanen, Timo Joensuu, Anna Kanerva, Akseli Hemminki
出版事項 2015Artigo
関連主題
Biology
Cancer research
Immune system
Immunology
Immunotherapy
Medicine
Genetics
Oncolytic adenovirus
Oncolytic virus
Biochemistry
Cell
Cell therapy
Cytokine
Gene
Internal medicine
T cell
Tumor necrosis factor alpha
Adoptive cell transfer
CD154
CD40
CD8
Cancer
Cell culture
Chemotherapy
Cytotoxic T cell
Doxorubicin
Etoposide
Genetic enhancement
Hamster
Ifosfamide